UNITED
STATES SECURITIES AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of Report (Date of earliest event reported)
IMMTECH
PHARMACEUTICALS, INC.
(Exact
name of registrant as specified in its charter)
|
|
|
|
|
|
|
(State
or Other Jurisdiction of Incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer Identification No.)
|
One
North End Avenue
New
York, New York 10282
(Address
of Principal Executive Offices, including Zip Code)
(212)
791-2911
(Registrant’s
telephone number, including area code)
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
| ITEM
5.02(e) |
DEPARTURE
OF DIRECTORS OR CERTAIN OFFICERS, ELECTION OF DIRECTORS, APPOINTMENT
OF
CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN
OFFICERS |
On
November 13, 2007, the Compensation Committee (the “Committee”) of the Board of
Directors (the “Board”) of Immtech Pharmaceuticals, Inc. (the “Company”)
recommended to the Board, and the Board approved the grant of stock options
to
purchase 90,000 shares of the Company’s common stock to certain of its executive
officers, pursuant to the Company’s 2000 Stock Incentive Plan.
The
Company awarded the stock options to these persons as follows:
| |
|
|
Number
of Shares of Common |
| |
|
|
|
| Name |
Title |
|
Stock
Underlying Award |
| |
|
|
|
| Gary
C. Parks |
Secretary,
Treasurer and Chief |
|
45,000 |
| |
|
|
|
| |
Financial
Officer |
|
|
| |
|
|
|
| Carol
Ann Olson |
Senior
Vice President and Chief |
|
45,000 |
| |
Medical
Officer |
|
|
The
exercise price of the stock option is $6.35 per share, the fair market value
of
the Company’s common stock on the date of grant. The stock options vest in equal
monthly installments over a period of 24 months from the date of the grant
and
expire ten years from the date of the grant.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
IMMTECH
PHARMACEUTICALS, INC. |
| |
|
|
| |
(Registrant) |
| |
|
|
| |
By: |
/s/
Eric L.
Sorkin
|
| |
|
|
| |
|
Eric
L. Sorkin |
| |
|
Chief
Executive Officer and President |
Date: November
15, 2007